Replies to post #823405 on NorthWest Biotherapeutics Inc (NWBO)

[sage007]

There are no confirmed details on where that EZPZ site is getting these data feeds from. The term dark pool is just that - dark pool for a reason. Any site can just make up these numbers. I don’t believe that number for a second. I wouldn’t be surprised if ILtech is the chairman of the board of EZPZ.

[Chiugray]

Correction: Step 2: Calculate the implied Retail shares existing [not "voted"], based on various voting participation rates:

[ilovetech]

🏛️ (Ref: Chiugray Post #1688721)
"The Check-Figure Confirmation: Voting Math vs. The Sovereign Vault"
"Kudos to Chiugray (Post #1688721) for the heavy lifting on the ASM voting forensics. This is the 'Check-Figure' that validates the Sovereign Vault extraction I’ve been tracking on the LSE tape.
The 8-K filing from January 2nd is the anchor. It confirms a 77.4% quorum. In a stock that is nearly 98% retail-owned, hitting 77% participation is a statistical unicorn. As Chiugray noted, the national retail voting average is only 28%. Even if we assume NWBO longs are twice as motivated as the average investor (50% participation), the math still implies a massive 'Synthetic Float' that has been 'trimmed' to fit the official OS.
This over-voting is the mechanical proof of the 2.6B+ share short position. When you combine this with the April 21 [EFFECT] muzzle I identified earlier, the picture is clear: The 'Cabal' is currently trimming the truth to hide a structural deficit that the upcoming UK launch will force into the light.
The math doesn't lie. The vault is full. Stay Sovereign."

[SinfullyKorean]

THIS is a idea that I can get behind. I've never voted, high participation in a stock that has only tested patience is quite abnormal. Survey rates for organizations are awful and that's for your fucking job. I honestly wasn't expecting MOASS but this might hit the news.

[Investor082]

Make sure LP gets behind retail and doesn’t pull the rug. She dumped 1.2B+ shares in the last 5 years, unfortunately.

No excuses when she continues to dilute in pennies, OK? ;)

We will monitor daily dilution from the day the UK decision is announced, LOL!

[AngeloFoca]

This is an EXTREMELY interesting post and very intuitive way of resolving issues.

Thank You, Chiugray


.

[Chiugray]

I am adding a second check figure to ballpark that the Total Short position is likely “much greater” than 1B shares. I call this, The “Missing Valuation” Check Figure.

The Data: 3 Catalyst and Suppression Cycles
- Cycle 1 (2015-17): NWBO hit $1B mkt cap (Woodford Investment). Value down to $0.03B. ($0.9B erased)

- Cycle 2 (2020-22): NWBO hits $1.4B mkt cap (Phase 3 Data Lock/Sawston licensing) Value taken down to $0.3B. ($1.1B erased)

- Cycle 3 (2022-26): NWBO hits $1.0B mkt cap (JAMA Publication/MAA filing) Value take down to $0.3B. ($0.7B erased)

The Logic:
In a functional market, value is "sticky" after major de-risking events (like a successful Phase 3 peer-reviewed in JAMA). For NWBO, that value was "taken down" every time they reached important milestones.

The Math:
- Total value erased: $2.7B
- Est. average price (2020-26): $0.75/share
- Implied share displacement: $2.7B divided by $0.75 = 3.6B shares

Key concept:
- Catalysts creates spikes in buying demand
- “Absorb 3.6B shares” means Buyers bought 3.6B shares,
- But instead of buying at higher prices (price discovery during catalyst),
- The allegedly market manipulators created “phantom” naked shares and sold them to these Buyers at lower and lower prices.

Summary
To erase $2.7B in fundamental value during a period of clinical success, the market would have had to "absorb" the equivalent of 3.6B shares of selling pressure. These shorted shares would also hypothetically mean 3.6B shares were added to the cumulative Total Short Position.


References:
I laid out a summary of NWBO’s key events and valuations in this post.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177490927